The study — led by Martin Makary, MD, with the department of surgery at Baltimore-based Johns Hopkins Medicine — examined Medicare billing records for 3,248 hospitals nationwide in 2014. Researchers identified significant variation between submitted charges and the Medicare reimbursement amount across oncology specialty services.
Overall, specialty departments charged a median of up to 4.1 times more than the Medicare reimbursement amount, according to a news release. For radiology, the charge was a median of 3.7 times more, and for hematology/oncology, 2.3 times more. Medical oncology departments charged a median of 2.4 times more; radiation oncology 3.6 times more; and pathology 4.1 more.
“High markups exist for oncology services, and further legislation is needed to protect patients from highly variable pricing and to address disparities in access to high-quality cancer care,” the study’s authors concluded.
More articles on healthcare finance:
Trump’s 2019 budget blueprint: 15 healthcare takeaways
Pennsylvania hospital loses tax-exempt status: 4 things to know
North Carolina treasurer asks UNC Health Care for $1B bond to ensure cost savings from pending merger
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
